You need at least Flash Player v10.1.50.392 to view this page.

Get Adobe Flash player

You need at least Flash Player v10.1.50.392 to view this page.

Get Adobe Flash player

You need at least Flash Player v10.1.50.392 to view this page.

Get Adobe Flash player

You need at least Flash Player v10.1.50.392 to view this page.

Get Adobe Flash player

ICAV Update

June 10 - Canada and India sign MOU to treat infectious diseases:

Canada’s International Consortium on Anti-Virals (ICAV) and the Indian Council of Medical Research (ICMR) signed a Memorandum of Understanding for Cooperation and the Acceleration of Development of Anti-Infective Therapies.

This agreement is aimed at developing a collaborative program for the treatment of major infectious diseases, particularly from neglected, newly-emerging and re-emerging viral, bacterial and parasitic threats.

Under this MOU, the ICAV India secretariat will be established in Pune at the National AIDS Research Institute, India

india-june2016

Canada House in Delhi in the presence of the acting High Commissioner, Jess Dutton

View Facebook Announcement 

ICAV Events

A few words about us

The International Consortium on Anti-Virals (ICAV) is a not-for-profit drug development organization dedicated to the discovery and development of anti-microbial therapies for neglected and emerging diseases.

ICAV's goal is to accelerate the delivery of drugs to patients that are effective and accessible to all patients in need.

News from the World Health Organization